RespireRx Pharmaceuticals Inc. Note Agreements
27 Contracts & Agreements
- RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Demand Promissory Note dated April 10, 2024 (Filed With SEC on April 16, 2024)
- Amended and Restated Convertible Note due January 30, 2025 in the amount of $54,000 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)
- Amended and Restated Convertible Note due January 30, 2025 in the amount of $40,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)
- Amended and Restated Convertible Note due January 30, 2025 in the amount of $85,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)
- RespireRx-Marc M. Radin PC Demand Promissory Note dated May 22, 2023 (Filed With SEC on May 24, 2023)
- RespireRx-Arnold Lippa Family Trust of 2007 Demand Promissory Note dated May 22, 2023 (Filed With SEC on May 24, 2023)
- Promissory Note template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds, identical in terms except as to... (Filed With SEC on November 17, 2022)
- Piggy-back Registrations Rights Agreement template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds,... (Filed With SEC on November 17, 2022)
- Securities Purchase Agreement template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds, identical in terms... (Filed With SEC on November 17, 2022)
- Promissory Note dated, April 14, 2022 (Filed With SEC on April 15, 2022)
- Amendment No. 1 to 8% Fixed Promissory Note, dated September 30, 2020 (Filed With SEC on October 14, 2020)
- 10% Convertible Note, dated July 30, 2020, in favor of EMA Financial, LLC (Filed With SEC on October 14, 2020)
- 8% Fixed Promissory Note, dated July 28, 2020, in favor of White Lion Capital, LLC (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated June 7, 2020, in favor of Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated April 15, 2020, in favor of Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)
- RespireRx Pharmaceuticals Inc. 10% Convertible Redeemable Note due November 4, 2020, dated November 4, 2019 (Filed With SEC on October 14, 2020)
- 10% Convertible Note, dated October 22, 2019 (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated August 19, 2019 (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated May 17, 2019 (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated April 24, 2019 (Filed With SEC on October 14, 2020)
- Form of Demand Promissory Note (Filed With SEC on October 14, 2020)
- Form of Demand Promissory Note (Filed With SEC on October 14, 2020)
- Demand Promissory Note, dated June 16, 2015, held by Arnold S. Lippa on behalf of the Company (Filed With SEC on October 14, 2020)
- FORMOF DEMANDPROMISSORY NOTE (Filed With SEC on September 28, 2016)
- FORMOF DEMANDPROMISSORY NOTE (Filed With SEC on February 3, 2016)
- DEMANDPROMISSORY NOTE (Filed With SEC on June 19, 2015)
